Cardio Diagnostics
Get Started
Hero Background

Get Started

What Makes Our Tests Different

By combining epigenetics with AI, our tests go beyond traditional tests to measure an individual's unique molecular biology.

Non-Invasive

Non-Invasive

Our blood tests do not require fasting or exposure to radiation that could increase cancer risk.

Advanced

Cutting-Edge

Our technology combines epigenetics, genetics, and AI to more comprehensively assess heart health even in the absence of risk factors.

Evidence-Based

Evidence-Based

Our tests are clinically validated, backed by peer-reviewed publications and have high sensitivity and specificity.

Convenient

Accessible

Samples can be collected via phlebotomy in a clinical setting or patients can request a test virtually and collect their sample at home.

Tailored Solutions for Patients, Providers, and Employers

Patients

Take the first step today toward better heart health.

Request a Test
Patient

Providers

Advance prevention and detection of coronary heart disease with precision medicine insights.

Integrate Testing Into Your Practice
Provider

Employers

Protect your workforce and lower healthcare spend.

Offer Testing to Your Employees
Employer

Who We Serve

PatientsProvidersEmployers

Our Solutions

OverviewEpi+Gen CHD™PrecisionCHD™HeartRisk™CardioInnovate360™

Company

About UsAbout CVDCareersTechnologyResourcesContact Us

Investors

Stock InformationSEC FilingsPress ReleasesPresentationsEmail SubscriptionCorporate GovernanceContact Investor Relations
Contact Us

2026 Cardio Diagnostics, Inc.

Privacy PolicyTerms of UseHIPAA Notice

The Cardio Diagnostics clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical laboratory testing. The Epi+Gen CHD™ and PrecisionCHD™ tests were developed, and their performance characteristics were determined by Cardio Diagnostics. These tests should be ordered by a licensed healthcare provider, and test results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms, and other relevant clinical information. These tests are intended for clinical purposes and have not been cleared or approved by the U.S. Food and Drug Administration (FDA).

For the Epi+Gen CHD™ test, a lower risk result does not eliminate the possibility of a coronary heart disease event occurring or that coronary heart disease is present, and a higher risk result does not imply a diagnosis of coronary heart disease or that a coronary heart disease event will occur. For the PrecisionCHD™ test, a "Signal Detected" result is not a diagnosis of coronary heart disease, and a "Signal Not Detected" result does not eliminate the possibility that coronary heart disease is present or could occur in the future. False positive and false negative test results do occur. Rx only.

In addition to a federal CLIA license, the Cardio Diagnostics clinical laboratory holds active state clinical laboratory licenses in California, Maryland, Pennsylvania, and Rhode Island. The laboratory is not currently licensed to process patient samples originating from the state of New York.